Loading…
OptimizeRx Corporation is projected to rise to $6.89 by 2027, a +14% move from its current price of $6.05. OPRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $5.91 | $6.05 | $6.20 | +0.04% |
| Aug 5 | $5.85 | $6.05 | $6.27 | +0.08% |
| Aug 6 | $5.81 | $6.06 | $6.32 | +0.12% |
| Aug 7 | $5.77 | $6.06 | $6.36 | +0.15% |
| Aug 8 | $5.74 | $6.06 | $6.40 | +0.19% |
| Aug 9 | $5.71 | $6.06 | $6.43 | +0.23% |
| Aug 10 | $5.69 | $6.07 | $6.47 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.69 | $6.07 | $6.47 | +0.27% |
| Week 2 | $5.56 | $6.08 | $6.66 | +0.54% |
| Week 3 | $5.46 | $6.10 | $6.82 | +0.81% |
| Week 4 | $5.38 | $6.12 | $6.95 | +1.09% |
| Week 5 | $5.31 | $6.13 | $7.08 | +1.36% |
| Week 6 | $5.26 | $6.15 | $7.19 | +1.63% |
| Week 7 | $5.20 | $6.17 | $7.30 | +1.91% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms.
The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
OPRX trades at $6.05. Its market cap is $113.53M, and it ranks 4088. The forecast suggests a structured growth path ahead, with the 2026 average price at $6.05, rising to $10.37 by 2030, $20.16 by 2040, and $43.01 by 2050. ROI moves from 0% in 2026 to 71.4% by 2030 and 610.8% by 2050, with sentiment turning bullish in the later years.
A major floor 40.3% below — a decisive break under it would weaken the trend.
The nearest floor, 25.0% below — buyers have tended to step in here.
The nearest ceiling, 10.6% above — a clean break opens room to run.
A major ceiling 30.7% above — clearing it would confirm fresh momentum.
Key OPRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OPRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.28 | Sell | $6.24 | Sell |
| MA 10 | $6.35 | Sell | $6.30 | Sell |
| MA 20 | $6.40 | Sell | $6.23 | Sell |
| MA 50 | $5.66 | Buy | $6.07 | Sell |
| MA 100 | $6.01 | Buy | $6.76 | Sell |
| MA 200 | $9.72 | Sell | $8.41 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.25 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -157.28 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -9.02 | Sell |
| Bollinger %B (20,2) | 0.00 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.62 | Buy |
| Awesome (5,34) | 0.36 | Buy |
| Ultimate (7,14,28) | 33.24 | Neutral |
| Momentum (10) | -0.64 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 6.23 | Sell |
| ADX (14) | 20.49 | Sell |
| ATR (14) | 0.13 | Info |
The 30-day range is $5.16 to $7.10, and RSI14 sits at 50, signaling neutral momentum. SMA50 is $5.66 and SMA200 is $9.72. Support is at $4.54 and resistance is at $6.69. Annualized volatility is 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.54 | $6.05 | $7.40 | 0% | Neutral | |
| $5.56 | $6.89 | $9.01 | +14% | Neutral | |
| $6.33 | $8.05 | $10.88 | +33% | Bullish | |
| $7.41 | $9.62 | $13.35 | +59% | Bullish | |
| $7.84 | $10.36 | $14.71 | +71% | Bullish | |
| $7.76 | $10.43 | $15.09 | +72% | Bullish | |
| $8.21 | $11.20 | $16.49 | +85% | Bullish | |
| $8.54 | $11.82 | $17.68 | +95% | Bullish | |
| $9.21 | $12.91 | $19.61 | +113% | Bullish | |
| $10.56 | $14.99 | $23.07 | +148% | Bullish | |
| $13.41 | $20.17 | $32.85 | +233% | Bullish | |
| $25.94 | $43.00 | $76.12 | +611% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.54 | $6.05 | $7.15 | +0.00% |
| September 2026 | $5.18 | $6.10 | $7.38 | +0.87% |
| October 2026 | $5.28 | $6.27 | $7.65 | +2.69% |
| November 2026 | $5.15 | $6.14 | $7.56 | -2.03% |
| December 2026 | $4.99 | $5.97 | $7.40 | -2.76% |
Click any year to see its month-by-month OPRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, OPRX is projected to trade between $4.54 and $7.40, averaging $6.05 — a potential gain of 0% from today's $6.05. Price action looks broadly range-bound.
OptimizeRx Corporation's 2027 outlook centres on $6.89, within a $5.56 to $9.01 range. That is up +14% on the projected 2026 average. That marks a +14% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, OPRX could reach as high as $10.88, with a base case around $8.05 and support toward $6.33 — roughly +33% from $6.05. Momentum favours further upside here.
Expect OPRX to range from $7.41 to $13.35 through 2029. The $9.62 average target implies a +59% move from current prices. That is up +19% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The OPRX price prediction for 2030 points to an average of $10.36 (low $7.84, high $14.71) — a potential gain of +71% on today's $6.05. Momentum favours further upside here.
In 2031, OPRX is projected to trade between $7.76 and $15.09, averaging $10.43 — a potential gain of +72% from today's $6.05. That is up +1% on the projected 2030 average. Buyers look set to stay in control over this stretch.
OptimizeRx Corporation's 2032 outlook centres on $11.20, within a $8.21 to $16.49 range. That is up +7% on the projected 2031 average. That marks a +85% change versus current levels. Momentum favours further upside here.
By 2033, OPRX could reach as high as $17.68, with a base case around $11.82 and support toward $8.54 — roughly +95% from $6.05. Buyers look set to stay in control over this stretch.
Expect OPRX to range from $9.21 to $19.61 through 2034. The $12.91 average target implies a +113% move from current prices. That is up +9% on the projected 2033 average. Momentum favours further upside here.
The OPRX price prediction for 2035 points to an average of $14.99 (low $10.56, high $23.07) — a potential gain of +148% on today's $6.05. Buyers look set to stay in control over this stretch.
In 2040, OPRX is projected to trade between $13.41 and $32.85, averaging $20.17 — a potential gain of +233% from today's $6.05. That is up +35% on the projected 2035 average. Momentum favours further upside here.
OptimizeRx Corporation's 2050 outlook centres on $43.00, within a $25.94 to $76.12 range. That is up +113% on the projected 2040 average. That marks a +611% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in OPRX today (≈ 165.289256 OPRX) could be worth
$7,107.85
+$6,107.85 (+611%) by 2050 · US Dollar
Based on the average projected OPRX price of $43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OPRXwould be worth at today's price.
$1,000 invested in OPRX on Jul 31, 2025 (≈ 79.239303 OPRX) would be worth
$479.4
-$520.6 (-52.1%) today · 0.48× · US Dollar
Based on a OPRX entry price of $12.62 vs. today's $6.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.24 | $969.55 | -3.0% |
| 1 month ago | $6.08 | $995.07 | -0.5% |
| 3 months ago | $6.7 | $902.99 | -9.7% |
| 6 months ago | $10.92 | $554.03 | -44.6% |
| 1 year ago | $12.62 | $479.4 | -52.1% |
| All time (5.0y) ago | $57.47 | $105.27 | -89.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OPRX forecast.
Our base-case forecast reaches $12.00 around 2034.
Implied market cap at $12.00: $225.18M
The multi-year forecast shows a bullish trajectory starting in 2028 and continuing through 2050. 2026-2027 carry Neutral sentiment, then 2028-2050 Bullish. For context, the forecast gives 2028 avg $8.05 and 2029 avg $9.62, reaching 2030 avg $10.37; 2040 avg $20.16 and 2050 avg $43.01.
The implied ROI grows from 14.1% in 2027 to 610.8% by 2050. These are estimates and not guarantees; actual results may differ.
Tap a question to reveal the answer.
2030 forecast: avg $10.37, min $7.84, max $14.72, ROI 71.4%, sentiment BULLISH.
Forecast shows Neutral in 2026-2027, then BULLISH from 2028 onward. Avg prices rise from $6.05 in 2026 to $10.37 in 2030 and $43.01 by 2050, with ROI reaching 610.8% by 2050.
Yes—the 2040 forecast lists avg $20.16 and max $32.83.
Current price is $6.05.
30-day range: low $5.16, high $7.10.
OptimizeRx Corporation Community Discussion
0Share your OptimizeRx Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.